A. Ontogénie-des-plasmocytes-radbruch, G. Muehlinghaus, E. O. Luger, A. Inamine, K. Smith et al., Competence and competition: the challenge of becoming a long-lived plasma cell, Nat Rev Immunol, vol.6, issue.10, pp.741-50, 2006.

E. Campo, S. A. Pileri, N. L. Harris, H. Stein, and R. Siebert, The 2016 revision of the World Health Organization classification of lymphoid neoplasms, Classification WHO 2016 des tumeurs des tissus hématopoïétiques et lymphoïdes Swerdlow SH, vol.127, pp.2375-90, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01800015

J. J. Diagnostics-différentiels-du-lymphome-plasmablastique-castillo, M. Bibas, and R. N. Miranda, The biology and treatment of plasmablastic lymphoma, Blood, vol.125, issue.15, pp.2323-2353, 2015.

J. Cutanés-malysz, G. Talamo, J. Zhu, L. E. Clarke, M. G. Bayerl et al., Cutaneous involvement in multiple myeloma (MM): A case series with clinicopathologic correlation, Diagnostics différentiels des infiltrats plasmocytaires, vol.74, pp.878-84, 2016.

F. Delhommeau and A. Najman, Hématopoïèse normale et sa régulation, EMC Hématologie, vol.11, issue.1, pp.1-16, 2016.

K. A. Fairfax, A. Kallies, S. L. Nutt, and D. M. Tarlinton, Plasma cell development: from B-cell subsets to longterm survival niches, Semin Immunol, vol.20, issue.1, pp.49-58, 2008.

S. A. Oracki, J. A. Walker, M. L. Hibbs, L. M. Corcoran, and D. M. Tarlinton, Plasma cell development and survival, Immunol Rev, vol.237, issue.1, pp.140-59, 2010.

M. Shapiro-shelef and K. Calame, Regulation of plasma-cell development, Nat Rev Immunol, vol.5, issue.3, pp.230-272, 2005.

G. Russano-de-paiva, C. Laurent, L. Lamant, G. Delsol, and P. Brousset, Classification histopathologique, immunologique, cytogénétique et moléculaire des lymphomes non hodgkiniens, EMCHématologie, pp.1-23, 2009.

A. Radbruch, G. Muehlinghaus, E. O. Luger, A. Inamine, K. Smith et al., Competence and competition: the challenge of becoming a long-lived plasma cell, Nat Rev Immunol, vol.6, issue.10, pp.741-50, 2006.

D. Paus, T. G. Phan, T. D. Chan, S. Gardam, A. Basten et al., Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation, J Exp Med, vol.203, issue.4, pp.1081-91, 2006.

E. J. Kunkel and E. C. Butcher, Plasma-cell homing, Nat Rev Immunol, vol.3, issue.10, pp.822-831, 2003.

D. Suan, C. Sundling, and R. Brink, Plasma cell and memory B cell differentiation from the germinal center, Curr Opin Immunol, vol.45, pp.97-102, 2017.

K. Igarashi, K. Ochiai, and A. Muto, Architecture and dynamics of the transcription factor network that regulates B-to-plasma cell differentiation, J Biochem, vol.141, issue.6, pp.783-792, 2007.

K. L. Calame, K. Lin, and C. Tunyaplin, Regulatory mechanisms that determine the development and function of plasma cells, Annu Rev Immunol, vol.21, pp.205-235, 2003.

S. Dalle, L. Thomas, B. Balme, C. Dumontet, and C. Thieblemont, Primary cutaneous marginal zone lymphoma, Crit Rev Oncol Hematol, vol.74, issue.3, pp.156-62, 2010.

J. Alinikula and O. Lassila, Gene interaction network regulates plasma cell differentiation, Scand J Immunol, vol.73, issue.6, pp.512-521, 2011.

B. P. O'connor, M. Cascalho, and R. J. Noelle, Short-lived and long-lived bone marrow plasma cells are derived from a novel precursor population, J Exp Med, vol.195, issue.6, pp.737-782, 2002.

D. Tarlinton, A. Radbruch, F. Hiepe, and T. Dörner, Plasma cell differentiation and survival, Curr Opin Immunol, vol.20, issue.2, pp.162-171, 2008.

K. Moser, G. Muehlinghaus, R. Manz, H. Mei, C. Voigt et al., Long-lived plasma cells in immunity and immunopathology, Immunol Lett, vol.103, issue.2, pp.83-88, 2006.

G. Cassese, S. Arce, A. E. Hauser, K. Lehnert, B. Moewes et al., Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals, J Immunol, vol.171, issue.4, pp.1684-90, 2003.

S. Ingen-housz-oro and N. Ortonne, Les marqueurs membranaires de surface (clusters de différenciation) utilisés en dermatopathologie (1) : les marqueurs lymphocytaires, Annales de Dermatologie et de Vénéréologie, vol.142, issue.10, pp.598-606, 2015.

M. Costopoulos and M. L. Garff-tavernier, Immunophénotypage lymphocytaire dans les syndromes lymphoprolifératifs chroniques, EMC -Biologie médicale, vol.8, issue.4, pp.1-13, 2013.

B. Paiva, J. Almeida, M. Pérez-andrés, M. G. López, A. Rasillo et al., Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disorders, Cytometry B Clin Cytom, vol.78, issue.4, pp.239-52, 2010.

S. Kumar, T. Kimlinger, and W. Morice, Immunophenotyping in multiple myeloma and related plasma cell disorders, Best Pract Res Clin Haematol, vol.23, issue.3, pp.433-51, 2010.

D. Ribatti, The discovery of plasma cells: An historical note, Immunol Lett, vol.188, pp.64-71, 2017.

H. Harada, M. M. Kawano, N. Huang, Y. Harada, K. Iwato et al., Phenotypic difference of normal plasma cells from mature myeloma cells, Blood, vol.81, issue.10, pp.2658-63, 1993.

C. Ram-wolff, . Lymphomes-cutanés, and . Emc--hématologie, , vol.12, pp.1-12, 2017.

C. Ram-wolff, Lymphomes B cutanés. EMC -Hématologie, vol.11, issue.4, pp.1-9, 2016.

F. Grange, D. 'incan, M. Ortonne, N. Dalac, S. Laroche et al., Prise en charge des lymphomes B cutanés: recommandations du Groupe français d'étude des lymphomes cutanés, Annales de dermatologie et de vénéréologie, pp.523-531, 2010.

Y. H. Kim, R. Willemze, N. Pimpinelli, S. Whittaker, E. A. Olsen et al., TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC), Blood, vol.110, issue.2, pp.479-84, 2007.

S. H. Swerdlow, E. Campo, S. A. Pileri, N. L. Harris, H. Stein et al., The 2016 revision of the World Health Organization classification of lymphoid neoplasms, Blood, vol.127, issue.20, pp.2375-90, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01800015

T. Tüting and K. Bork, Primary plasmacytoma of the skin, J Am Acad Dermatol, vol.34, issue.2, pp.386-90, 1996.

Y. R. Woo, J. S. Kim, J. H. Lim, S. Hwang, M. Kim et al., Prevalence and clinicopathologic characteristics of multiple myeloma with cutaneous involvement: A case series from Korea, J Am Acad Dermatol, vol.78, issue.3, pp.471-479, 2018.

D. V. Kazakov, I. E. Belousova, B. Müller, G. Palmedo, A. V. Samtsov et al., Primary cutaneous plasmacytoma: a clinicopathological study of two cases with a long-term follow-up and review of the literature, J Cutan Pathol, vol.29, issue.4, pp.244-252, 2002.

M. D'incan and B. Vergier, Plasmocytomes cutanés primitifs, Bagot M, éditeur. Les lymphomes cutanés: Sous l'égide du Groupe français d'étude des lymphomes cutanés, pp.199-202, 2013.

F. Rongioletti, J. W. Patterson, and A. Rebora, The histological and pathogenetic spectrum of cutaneous disease in monoclonal gammopathies, J Cutan Pathol, vol.35, issue.8, pp.705-726, 2008.

M. Kremer, G. Ott, M. Nathrath, K. Specht, K. Stecker et al., Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis, J Pathol, vol.205, issue.1, pp.92-101, 2005.

C. Lacoste, S. Ingen-housz-oro, and N. Ortonne, Manifestations dermatologiques des gammapathies monoclonales : apport de l'histopathologie cutanée, Annales de Pathologie, vol.35, issue.4, pp.281-93, 2015.

L. Requena, H. Kutzner, G. Palmedo, E. Calonje, C. Requena et al., Cutaneous involvement in multiple myeloma: a clinicopathologic, immunohistochemical, and cytogenetic study of 8 cases, Arch Dermatol, vol.139, issue.4, pp.475-86, 2003.

R. D. Sellami, S. Sassi, K. Mrad, I. Abess, M. Driss et al., Plasmocytome cutané primitif, Annales de Pathologie, vol.27, issue.2, pp.130-132, 2008.

N. Malissen, C. Fabre, J. Joujoux, P. Bourquard, M. Dandurand et al., Plasmocytomes cutanés primitifs multiples. Annales de Dermatologie et de Vénéréologie, vol.141, pp.364-372, 2014.

L. Cerroni, Skin Lymphoma: The Illustrated Guide, vol.440, 2014.

M. A. Ballester-martínez, C. González-garcía, B. Fleta-asín, A. Burdaspal-moratilla, A. Santón-roldán et al., Cutaneous nodules as a diagnostic clue in multiple myeloma, Am J Dermatopathol, vol.35, issue.3, pp.377-80, 2013.

L. J. Medeiros, D. P. O'malley, N. P. Caraway, F. Vega, K. Elenitoba-johnson et al., AFIP Atlas of Tumor Pathology Series 4 | Lymph Node & Spleen, vol.25, 2017.

S. Serefhanoglu, I. C. Haznedaroglu, H. Goker, Y. Buyukasik, and O. I. Ozcebe, Multiple bulky cutaneous plasmacytomas with CNS relapse without bone marrow involvement during the course of a lambda light chain myeloma, Onkologie, vol.32, issue.11, pp.662-666, 2009.

B. Saka, N. Erten, G. Oztürk, C. Yilmaz, O. Dogan et al., Kappa light chain myeloma with initial cutaneous involvement, Ann Hematol, vol.85, issue.4, pp.272-276, 2006.

M. S. Daoud, J. A. Lust, R. A. Kyle, and M. R. Pittelkow, Monoclonal gammopathies and associated skin disorders, J Am Acad Dermatol, vol.40, issue.4, pp.536-544, 1999.

I. B. Bayer-garner, V. G. Prieto, and B. R. Smoller, Detection of clonality with kappa and lambda immunohistochemical analysis in cutaneous plasmacytomas, Arch Pathol Lab Med, vol.128, issue.6, pp.645-653, 2004.

N. Kato, K. Kimura, K. Yasukawa, and K. Aikawa, Metastatic cutaneous plasmacytoma: a case report associated with IgA lambda multiple myeloma and a review of the literature of metastatic cutaneous plasmacytomas associated with multiple myeloma and primary cutaneous plasmacytomas, J Dermatol, vol.26, issue.9, pp.587-94, 1999.

S. Swerdlow, E. Campo, N. Harris, E. Jaffe, S. Pileri et al., WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4 e éd, vol.2, 2017.

N. I. Comfere, G. Santiago, T. M. Peters, M. S. Knudson, R. A. Ketterling et al., Cutaneous extramedullary plasmacytoma: clinical, prognostic, and interphase cytogenetic analysis, Am J Dermatopathol, vol.35, issue.3, pp.357-63, 2013.

T. Green, J. Grant, R. Pye, and R. Marcus, Multiple primary cutaneous plasmacytomas, Arch Dermatol, vol.128, issue.7, pp.962-967, 1992.

I. B. Bayer-garner and B. R. Smoller, The spectrum of cutaneous disease in multiple myeloma, J Am Acad Dermatol, vol.48, issue.4, pp.497-507, 2003.

G. Santos, L. Sousa, T. Fernandes, and A. João, Case for diagnosis. Cutaneous involvement associated to multiple myeloma, An Bras Dermatol, vol.89, issue.1, pp.173-177, 2014.

A. Jurczyszyn, M. Olszewska-szopa, V. Hungria, E. Crusoe, T. Pika et al., Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients, Leuk Lymphoma, vol.57, issue.9, pp.2071-2077, 2016.

J. Bladé, F. De-larrea, C. Rosiñol, L. Cibeira, M. T. Jiménez et al., Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach, J Clin Oncol, vol.29, issue.28, pp.3805-3817, 2011.

D. S. Tsang, L. W. Le, V. Kukreti, and A. Sun, Treatment and outcomes for primary cutaneous extramedullary plasmacytoma: a case series, Curr Oncol, vol.23, issue.6, pp.630-676, 2016.

M. L. Walby, J. Ahluwalia, and D. R. Mehregan, Primary cutaneous plasmacytoma in an HIV-positive patient, Int J Dermatol, vol.55, issue.4, pp.464-471, 2016.

T. Koletsa, A. Patsatsi, I. Kostopoulos, C. Kartsios, I. Korantzis et al., A case of a primary cutaneous plasmacytoma presenting in adolescence, Am J Dermatopathol, vol.34, issue.5, pp.537-577, 2012.

F. Lallemand, L. Fritsch, C. Cywiner-golenzer, and W. Rozenbaum, Multiple myeloma in an HIV-positive man presenting with primary cutaneous plasmacytomas and spinal cord compression, J Am Acad Dermatol, vol.39, issue.3, pp.506-514, 1998.

B. Güvenç, A. Canataro?lu, Y. Gümürdülü, D. Gümürdülü, and S. Payda?t, Multiple myeloma with skin involvement, J Eur Acad Dermatol Venereol, vol.15, issue.4, pp.328-337, 2001.

E. Wang and M. Stoecker, Primary cutaneous giant cell plasmacytoma in an organ transplant recipient: a rare presentation of a posttransplant lymphoproliferative disorder, Am J Dermatopathol, vol.32, issue.5, pp.479-85, 2010.

M. Buffet, N. Dupin, A. Carlotti, D. Muret, A. Tulliez et al.,

, Ann Dermatol Venereol, vol.131, issue.12, pp.1085-91, 2004.

H. A. Papadaki, K. Stefanaki, P. Kanavaros, P. Katonis, H. Papastathi et al., Epstein-Barr virus-associated high-grade anaplastic plasmacytoma in a renal transplant patient, Leuk Lymphoma, vol.36, issue.3-4, pp.411-416, 2000.

V. Willoughby, A. Werlang-perurena, A. Kelly, J. Francois, and L. R. Donner, Primary cutaneous plasmacytoma (posttransplant lymphoproliferative disorder, plasmacytoma-like) in a heart transplant patient, Am J Dermatopathol, vol.28, issue.5, pp.442-447, 2006.

A. Carbonnelle, E. Mahé, E. Morelon, B. Varet, H. Kreis et al., Plasmocytome cutané EBV+ isolé chez une malade transplantée rénale : efficacité d'un traitement par rituximab, Annales de Dermatologie et de Vénéréologie, vol.131, issue.12, pp.1081-1085, 2004.

A. Martorell, F. Millan-parrilla, and E. Gimeno-carpio, Cutaneous involvement in multiple myeloma mimicking acral-lentiginous melanoma, J Am Acad Dermatol, vol.62, issue.6, pp.1076-1084, 2010.

A. Ah-weng, R. Charles-holmes, P. Rose, S. Basu, J. R. Marsden et al., Multiple cutaneous plasmacytomas following an autologous peripheral stem cell transplant, Clin Exp Dermatol, vol.27, issue.4, pp.293-298, 2002.

A. Selvarajah, C. Winnall, and A. Powell, Cutaneous Plasmacytoma: A Rare Complication of Multiple Myeloma and Permanent Pacemaker Insertion. Heart, Lung and Circulation, vol.27, p.159, 2018.

J. Yoo, J. M. Kim, M. Jue, M. Park, H. Choi et al., Metastasis of Multiple Myeloma at the Fracture Site, Ann Dermatol, vol.29, issue.4, pp.483-489, 2017.

T. Karasawa, T. Matsumoto, and M. Akiyama, Metastatic skin lesions of multiple myeloma presenting as two extraordinarily large subcutaneous tumors, Int J Dermatol, vol.52, issue.12, pp.1568-70, 2013.

R. Soutar, H. Lucraft, G. Jackson, A. Reece, J. Bird et al., Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma, Br J Haematol, vol.124, issue.6, pp.717-743, 2004.

J. L. Wozney, F. Ahmed, M. G. Bayerl, W. C. Ehmann, and G. Talamo, Skin involvement in immunoglobulin E multiple myeloma, J Clin Oncol, vol.27, issue.4, pp.637-645, 2009.

V. Viseux, P. Schoenlaub, S. Danhier, J. Vilque, and P. Plantin, Plasmocytomes cutanés multiples traités par applications locales de miltéfosine, Annales de Dermatologie et de Vénéréologie, vol.131, issue.2, p.204, 2004.

A. Siniscalchi, S. Fratoni, G. Santeusanio, D. Poeta, G. De-fabritiis et al., Cutaneous involvement in multiple myeloma and bortezomib, Ann Hematol, vol.88, issue.11, pp.1137-1146, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00535041

A. Gozzetti, M. Defina, and M. Bocchia, Cutaneous myeloma and bortezomib, Ann Hematol, vol.88, issue.10, p.1045, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00535075

S. Nguyen and A. Dagnault, Radiotherapy for multiple myeloma with skin involvement, Curr Oncol, vol.17, issue.5, pp.74-81, 2010.

J. Liu, R. Bakst, R. Phelps, S. Jagannath, and S. Blacksburg, Radiation therapy for secondary cutaneous plasmacytomas, Case Rep Hematol, pp.1-5, 2013.

S. R. Floyd, L. Pantanowitz, D. F. Mcdermott, J. Yannucci, J. A. Driver et al., Plasma cell problems: Case 1. Disseminated cutaneous plasmacytomas treated with total skin electron radiotherapy, J Clin Oncol, vol.23, issue.13, pp.3138-3178, 2005.

J. Malysz, G. Talamo, J. Zhu, L. E. Clarke, M. G. Bayerl et al., Cutaneous involvement in multiple myeloma (MM): A case series with clinicopathologic correlation, J Am Acad Dermatol, vol.74, issue.5, pp.878-84, 2016.

L. M. Muscardin, A. Pulsoni, and L. Cerroni, Primary cutaneous plasmacytoma: report of a case with review of the literature, J Am Acad Dermatol, vol.43, issue.5, pp.962-967, 2000.

M. Ozsahin, R. W. Tsang, P. Poortmans, Y. Belkacémi, M. Bolla et al., Outcomes and patterns of failure in solitary plasmacytoma: a multicenter Rare Cancer Network study of 258 patients, Int J Radiat Oncol Biol Phys, vol.64, issue.1, pp.210-217, 2006.

S. M. Sanal, M. Yaylaci, K. A. Mangold, and C. G. Pantazis, Extensive extramedullary disease in myeloma. An uncommon variant with features of poor prognosis and dedifferentiation, Cancer, vol.77, issue.7, pp.1298-302, 1996.

C. Araújo, H. Marques, J. C. Fernandes, A. Pardal, and C. Brito, Cutaneous plasmacytomas secondary to nonsecretory multiple myeloma, J Dermatolog Clin Res, vol.2, issue.3, p.1022, 2014.

J. Autier, M. Buffet, L. Pinquier, A. Merlat-guitard, A. Carlotti et al., Cutaneous Waldenstrom's macroglobulinemia with « deck-chair » sign treated with cyclophosphamide, J Am Acad Dermatol, vol.52, issue.2, pp.45-52, 2005.

S. Oscoz-jaime, A. D. Agulló-pérez, C. Llanos-chavarri, and J. I. Yanguas-bayona, Cutaneous Infiltration due to Waldenström Macroglobulinemia, Actas Dermosifiliogr, vol.109, issue.1, pp.75-83, 2018.

L. Gressier, C. Hotz, J. Lelièvre, A. Carlotti, M. Buffet et al., Cutaneous macroglobulinosis: a report of 2 cases, Arch Dermatol, vol.146, issue.2, pp.165-174, 2010.

T. Yokote, T. Akioka, S. Oka, S. Hara, K. Kobayashi et al., Cutaneous infiltration with Waldenström macroglobulinemia, Leuk Res, vol.30, issue.9, pp.1207-1217, 2006.

V. Alegría-landa, L. Prieto-torres, C. Santonja, R. Córdoba, R. Manso et al., MYD88 L265P mutation in cutaneous involvement by Waldenström macroglobulinemia, J Cutan Pathol, 2017.

I. Chan, E. Calonje, and S. J. Whittaker, Cutaneous Waldenström's macroglobulinaemia, Clin Exp Dermatol, vol.28, issue.5, pp.491-493, 2003.

B. J. Camp and C. M. Magro, Cutaneous macroglobulinosis: a case series, J Cutan Pathol, vol.39, issue.10, pp.962-70, 2012.

R. E. Tichenor, J. M. Rau, and F. A. Mantz, Macroglobulinemia cutis, Arch Dermatol, vol.114, issue.2, pp.280-281, 1978.

D. Lipsker and P. Boeckler, Manifestations cutanées associées aux paraprotéines : mécanismes des atteintes cutanées, La Presse Médicale, vol.36, issue.7-8, pp.1135-1175, 2008.

E. Durot, C. Tomowiak, A. Michallet, J. Dupuis, B. Hivert et al., Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO), Br J Haematol, vol.179, issue.3, pp.439-487, 2017.

L. Cerroni, Cutaneous marginal zone lymphoma (cutaneous MALT lymphoma) and variants, Skin lymphoma, pp.201-220, 2014.

D. Elder, D. Massi, R. Scolyer, and R. Willemze, WHO Classification of Skin Tumours. 4 e éd, vol.11, 2018.

H. Takino, C. Li, S. Hu, T. Kuo, E. Geissinger et al., Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathological study of cases from Asia, Germany, and the United States, Mod Pathol, vol.21, issue.12, pp.1517-1543, 2008.

C. B. Hope and L. B. Pincus, Primary Cutaneous B-cell Lymphomas, Clin Lab Med, vol.37, issue.3, pp.547-74, 2017.

U. Sundram, Primary Cutaneous B-Cell Lymphomas, Surg Pathol Clin, vol.7, issue.2, pp.253-83, 2014.

I. Brenner, S. Roth, B. Puppe, M. Wobser, A. Rosenwald et al., Primary cutaneous marginal zone lymphomas with plasmacytic differentiation show frequent IgG4 expression, Mod Pathol, vol.26, issue.12, pp.1568-76, 2013.

J. T. Edinger, J. A. Kant, and S. H. Swerdlow, Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets, Am J Surg Pathol, vol.34, issue.12, pp.1830-1871, 2010.

S. H. Swerdlow, Cutaneous marginal zone lymphomas, Semin Diagn Pathol, vol.34, issue.1, pp.76-84, 2017.

V. G. Frings, K. Röding, A. Strate, A. Rosenwald, S. Roth et al., Paraproteinaemia in Primary Cutaneous Marginal Zone Lymphoma, Acta Derm Venereol, vol.98, issue.10, pp.956-62, 2018.

F. Vega, P. Lin, and L. J. Medeiros, Extranodal lymphomas of the head and neck, Ann Diagn Pathol, vol.9, issue.6, pp.340-50, 2005.

G. Palmedo, M. Hantschke, A. Rütten, T. Mentzel, W. Kempf et al., Primary cutaneous marginal zone B-cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH/BCL2 and the t(14;18)(q32;q21) IGH/MALT1 translocation: an indicator for clonal transformation towards higher-grade B-cell lymphoma?, Am J Dermatopathol, vol.29, issue.3, pp.231-237, 2007.

M. Wobser, K. Maurus, S. Roth, S. Appenzeller, G. Weyandt et al., Myeloid differentiation primary response 88 mutations in a distinct type of cutaneous marginal-zone lymphoma with a nonclass-switched immunoglobulin M immunophenotype, Br J Dermatol, vol.177, issue.2, pp.564-570, 2017.

A. L. Suárez, M. Pulitzer, S. Horwitz, A. Moskowitz, C. Querfeld et al., Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification, J Am Acad Dermatol, vol.69, issue.3, pp.341-343, 2013.

I. Amitay-laish, M. Tavallaee, J. Kim, R. T. Hoppe, L. Million et al., Paediatric primary cutaneous marginal zone B-cell lymphoma: does it differ from its adult counterpart?, Br J Dermatol, vol.176, issue.4, pp.1010-1030, 2017.

C. M. Magro, A. Yang, and G. Fraga, Blastic marginal zone lymphoma: a clinical and pathological study of 8 cases and review of the literature, Am J Dermatopathol, vol.35, issue.3, pp.319-345, 2013.

W. Kempf and C. A. Sander, Classification of cutaneous lymphomas -an update, Histopathology, vol.56, issue.1, pp.57-70, 2010.

J. Guitart, J. Deonizio, T. Bloom, M. E. Martinez-escala, T. M. Kuzel et al., High incidence of gastrointestinal tract disorders and autoimmunity in primary cutaneous marginal zone B-cell lymphomas, JAMA Dermatol, vol.150, issue.4, pp.412-420, 2014.

A. L. Suárez, C. Querfeld, S. Horwitz, M. Pulitzer, A. Moskowitz et al., Primary cutaneous B-cell lymphomas: part II. Therapy and future directions, J Am Acad Dermatol, vol.69, issue.3, pp.343-344, 2013.

M. Y. Park, H. J. Jung, J. E. Park, and Y. C. Kim, Pediatric primary cutaneous marginal zone B-cell lymphoma treated with intralesional rituximab, Eur J Dermatol, vol.20, issue.4, pp.533-537, 2010.

R. Willemze, E. Hodak, P. L. Zinzani, L. Specht, M. Ladetto et al., Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, vol.24, issue.6, pp.149-54, 2013.

O. Servitje, C. Muniesa, Y. Benavente, V. Monsálvez, M. P. Garcia-muret et al., Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients, Journal of the American Academy of Dermatology, vol.69, issue.3, pp.357-65, 2013.

O. Servitje, F. Gallardo, T. Estrach, R. M. Pujol, A. Blanco et al., Primary cutaneous marginal zone B-cell lymphoma: a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases, Br J Dermatol, vol.147, issue.6, pp.1147-58, 2002.

R. A. Wilcox, Cutaneous B-cell lymphomas: 2016 update on diagnosis, risk-stratification, and management, Am J Hematol, vol.91, issue.10, pp.1052-1057, 2016.

D. Heiser, H. Müller, W. Kempf, K. Eisendle, and B. Zelger, Primary cutaneous plasmablastic lymphoma of the lower leg in an HIV-negative patient, J Am Acad Dermatol, vol.67, issue.5, pp.202-207, 2012.

L. B. Jordan, A. M. Lessells, and J. R. Goodlad, Plasmablastic lymphoma arising at a cutaneous site, Histopathology, vol.46, issue.1, pp.113-118, 2005.

L. Taddesse-heath, A. Meloni-ehrig, J. Scheerle, J. C. Kelly, and E. S. Jaffe, Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features, Mod Pathol, vol.23, issue.7, pp.991-1000, 2010.

S. Verma, G. J. Nuovo, P. Porcu, R. A. Baiocchi, A. N. Crowson et al., Epstein-Barr virus-and human herpesvirus 8-associated primary cutaneous plasmablastic lymphoma in the setting of renal transplantation, J Cutan Pathol, vol.32, issue.1, pp.35-44, 2005.

M. Gilaberte, F. Gallardo, B. Bellosillo, P. Saballs, C. Barranco et al., Recurrent and self-healing cutaneous monoclonal plasmablastic infiltrates in a patient with AIDS and Kaposi sarcoma, Br J Dermatol, vol.153, issue.4, pp.828-860, 2005.

J. Castillo, L. Pantanowitz, and B. J. Dezube, HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases, Am J Hematol, vol.83, issue.10, pp.804-813, 2008.

F. Vega, C. Chang, L. J. Medeiros, M. M. Udden, J. H. Cho-vega et al., Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles, Mod Pathol, vol.18, issue.6, pp.806-821, 2005.

L. Colomo, F. Loong, S. Rives, S. Pittaluga, A. Martínez et al., Diffuse large Bcell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities, Am J Surg Pathol, vol.28, issue.6, pp.736-783, 2004.

J. Dales, A. Harket, D. Bagnères, L. Andrac-meyer, L. Xerri et al.,

, Ann Pathol, vol.25, issue.1, pp.45-54, 2005.

H. Y. Dong, D. T. Scadden, L. De-leval, Z. Tang, P. G. Isaacson et al., Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm, Am J Surg Pathol, vol.29, issue.12, pp.1633-1674, 2005.

P. Horna, J. R. Hamill, L. Sokol, and L. F. Glass, Primary cutaneous plasmablastic lymphoma in an immunocompetent patient, J Am Acad Dermatol, vol.69, issue.5, pp.274-280, 2013.

W. Liu, M. E. Lacouture, J. Jiang, M. Kraus, J. Dickstein et al., KSHV/HHV8-associated primary cutaneous plasmablastic lymphoma in a patient with Castleman's disease and Kaposi's sarcoma, J Cutan Pathol, vol.33, issue.2, pp.46-51, 2006.

N. Dupin, T. L. Diss, P. Kellam, M. Tulliez, M. Q. Du et al., HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma, Blood, vol.95, issue.4, pp.1406-1418, 2000.

S. Deloose, L. A. Smit, F. T. Pals, M. Kersten, C. Van-noesel et al., High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma, Leukemia, vol.19, issue.5, pp.851-856, 2005.

A. M. Bogusz, A. C. Seegmiller, R. Garcia, P. Shang, R. Ashfaq et al., Plasmablastic lymphomas with MYC/IgH rearrangement: report of three cases and review of the literature, Am J Clin Pathol, vol.132, issue.4, pp.597-605, 2009.

C. M. Harmon and L. B. Smith, Plasmablastic Lymphoma: A Review of Clinicopathologic Features and Differential Diagnosis, Arch Pathol Lab Med, vol.140, issue.10, pp.1074-1082, 2016.

I. Simonitsch-klupp, I. Hauser, G. Ott, J. Drach, J. Ackermann et al., Diffuse large Bcell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome, Leukemia, vol.18, issue.1, pp.146-55, 2004.

J. J. Castillo, M. Bibas, and R. N. Miranda, The biology and treatment of plasmablastic lymphoma, Blood, vol.125, issue.15, pp.2323-2353, 2015.

A. Valera, O. Balagué, L. Colomo, A. Martínez, J. Delabie et al., IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas, Am J Surg Pathol, vol.34, issue.11, pp.1686-94, 2010.

P. Rafaniello-raviele, G. Pruneri, and E. Maiorano, Plasmablastic lymphoma: a review, Oral Dis, vol.15, issue.1, pp.38-45, 2009.

H. J. Delecluse, I. Anagnostopoulos, F. Dallenbach, M. Hummel, T. Marafioti et al., Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection, Blood, vol.89, issue.4, pp.1413-1433, 1997.

J. J. Castillo, E. S. Winer, D. Stachurski, K. Perez, M. Jabbour et al., Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic lymphoma, Oncologist, vol.15, issue.3, pp.293-302, 2010.

C. L. Black, E. Foster-smith, I. D. Lewis, R. J. Faull, and S. K. Sidhu, Post-transplant plasmablastic lymphoma of the skin, Australas J Dermatol, vol.54, issue.4, pp.277-82, 2013.

S. Loghavi, K. Alayed, T. N. Aladily, Z. Zuo, S. Ng et al., Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients, J Hematol Oncol, vol.8, p.65, 2015.

L. Lin, X. Zhang, M. Dong, L. Li, X. Wang et al., Human immunodeficiency virus-negative plasmablastic lymphoma: A case report and literature review, Medicine, vol.96, issue.7, p.6171, 2017.

P. Häusermann, N. Khanna, M. Buess, P. H. Itin, M. Battegay et al., Cutaneous plasmablastic lymphoma in an HIV-positive male: an unrecognized cutaneous manifestation, Dermatology (Basel), vol.208, issue.3, pp.287-90, 2004.

T. Boye, P. Calvet, B. Fournierl, B. Guennoc, M. Pavic et al., Lymphome B cutané plasmablastique post-transplantation à type d'ulcère de jambe : premiere observation, Rev Méd Interne, vol.23, p.119, 2002.

I. S. Tiong, M. Strauss, M. Lau, and S. Chiruka, Cutaneous plasmablastic lymphoma in an immunocompetent patient with long-term pyrimethamine use for essential thrombocythemia: a case report and literature review, Case Rep Hematol, pp.1-6, 2013.

M. Redmond, J. Quinn, P. Murphy, S. Patchett, and M. Leader, Plasmablastic lymphoma presenting as a paravertebral mass in a patient with Crohn's disease after immunosuppressive therapy, J Clin Pathol, vol.60, issue.1, pp.80-81, 2007.

U. Eke, G. Pratt, R. Muc, and A. Heagerty, Cutaneous plasmablastic lymphoma in a nonimmunocompromised patient, J Am Acad Dermatol, vol.69, issue.6, pp.315-322, 2013.

B. E. Beltran, P. Quiñones, G. Sanchez, A. Paredes, C. Moises et al., Primary cutaneous plasmablastic lymphoma in an immunocompetent patient: is it associated with an indolent course?, Leuk Lymphoma, vol.59, issue.7, pp.1753-1758, 2018.

S. Apichai, A. Rogalska, I. Tzvetanov, Z. Asma, E. Benedetti et al., Multifocal cutaneous and systemic plasmablastic lymphoma in an infant with combined living donor small bowel and liver transplant, Pediatr Transplant, vol.13, issue.5, pp.628-659, 2009.

P. Chabay, D. Matteo, E. Lorenzetti, M. Gutierrez, M. Narbaitz et al., Vulvar plasmablastic lymphoma in a HIV-positive child: a novel extraoral localisation, J Clin Pathol, vol.62, issue.7, pp.644-650, 2009.

A. Jambusaria, D. Shafer, H. Wu, T. Al-saleem, and C. Perlis, Cutaneous plasmablastic lymphoma, J Am Acad Dermatol, vol.58, issue.4, pp.676-684, 2008.

I. Nicol, T. Boye, F. Carsuzaa, L. Feier, C. Villette et al., Post-transplant plasmablastic lymphoma of the skin, Br J Dermatol, vol.149, issue.4, pp.889-91, 2003.

R. El-fakih, M. Almahayni, and M. Alsermani, Plasmablastic lymphoma presenting as exophytic skin lesions, Hematol Oncol Stem Cell Ther, vol.10, issue.3, pp.164-169, 2017.

S. Mani, T. Kodiatte, and M. Jagannati, A rare presentation of plasmablastic lymphoma as cutaneous nodules in an immunocompromised patient, Int J STD AIDS, vol.28, issue.6, pp.623-628, 2017.

M. Bibas, S. Grisetti, L. Alba, G. Picchi, D. Nonno et al., Patient with HIV-associated plasmablastic lymphoma responding to bortezomib alone and in combination with dexamethasone, gemcitabine, oxaliplatin, cytarabine, and pegfilgrastim chemotherapy and lenalidomide alone, J Clin Oncol, vol.28, issue.34, pp.704-712, 2010.

J. Morscio, D. Dierickx, J. Nijs, G. Verhoef, E. Bittoun et al., Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases, Am J Surg Pathol, vol.38, issue.7, pp.875-86, 2014.

J. J. Castillo, E. S. Winer, D. Stachurski, K. Perez, M. Jabbour et al., HIV-negative plasmablastic lymphoma: not in the mouth, Clin Lymphoma Myeloma Leuk, vol.11, issue.2, pp.185-194, 2011.

J. T. Geyer, J. A. Ferry, J. A. Longtine, T. J. Flotte, N. L. Harris et al., Characteristics of cutaneous marginal zone lymphomas with marked plasmacytic differentiation and a T cell-rich background, Am J Clin Pathol, vol.133, issue.1, pp.59-69, 2010.

J. W. Patterson, J. M. Parsons, R. M. White, J. E. Fitzpatrick, and E. Kohout-dutz, Cutaneous involvement of multiple myeloma and extramedullary plasmacytoma, J Am Acad Dermatol, vol.19, issue.5, pp.879-90, 1988.

A. C. Johnston, K. Naresh, T. Barwick, P. May, A. Karadimitris et al., Cutaneous presentation of an aggressive plasmablastic neoplasm indiscriminate between lymphoma and myeloma, Ann Hematol, vol.94, issue.4, pp.691-693, 2015.

E. D. Hsi, R. B. Lorsbach, F. Fend, and A. Dogan, Plasmablastic lymphoma and related disorders, Am J Clin Pathol, vol.136, issue.2, pp.183-94, 2011.

D. Romero-pérez, B. Martínez, M. Encabo-durán, and B. Cutaneous-pseudolymphomas, Actas Dermosifiliogr, vol.107, issue.8, pp.640-51, 2016.

C. Mitteldorf, W. Kempf, and . Cutaneous-pseudolymphoma, Surg Pathol Clin, vol.10, issue.2, pp.455-76, 2017.

W. Cheuk, K. Lee, C. Yuen, S. Chan, and J. , IgG4-related Sclerosing disease: a potential new etiology of cutaneous pseudolymphoma, Am J Surg Pathol, vol.33, issue.11, pp.1713-1722, 2009.

A. Goyal, J. B. Moore, D. Gimbel, J. B. Carter, D. Kroshinsky et al., PD-1, S-100 and CD1a expression in pseudolymphomatous folliculitis, primary cutaneous marginal zone B-cell lymphoma (MALT lymphoma) and cutaneous lymphoid hyperplasia, J Cutan Pathol, vol.42, issue.1, pp.6-15, 2015.

Y. Sato, M. Takeuchi, K. Takata, K. Ohno, N. Iwaki et al., Clinicopathologic analysis of IgG4-related skin disease, Mod Pathol, vol.26, issue.4, pp.523-555, 2013.

A. Khosroshahi, M. D. Carruthers, V. Deshpande, L. Leb, J. I. Reed et al., Cutaneous immunoglobulin G4-related systemic disease, Am J Med, vol.124, issue.10, pp.7-8, 2011.

R. Takayama, T. Ueno, and H. Saeki, Immunoglobulin G4-related disease and its skin manifestations, J Dermatol, vol.44, issue.3, pp.288-96, 2017.

Y. Tokura, H. Yagi, H. Yanaguchi, Y. Majima, A. Kasuya et al., IgG4-related skin disease, Br J Dermatol, vol.171, issue.5, pp.959-67, 2014.

S. Ingen-housz-oro, N. Ortonne, M. Elhai, Y. Allanore, P. Aucouturier et al., IgG4-related skin disease successfully treated by thalidomide: a report of 2 cases with emphasis on pathological aspects, JAMA Dermatol, vol.149, issue.6, pp.742-749, 2013.

A. E. Bennett, N. A. Fenske, P. Rodriguez-waitkus, and J. L. Messina, IgG4-related skin disease may have distinct systemic manifestations: a systematic review, Int J Dermatol, vol.55, issue.11, pp.1184-95, 2016.

T. Ikeda, M. Oka, H. Shimizu, M. Hatakeyama, H. Kanki et al., IgG4-related skin manifestations in patients with IgG4-related disease, Eur J Dermatol, vol.23, issue.2, pp.241-246, 2013.

T. Hattori, T. Miyanaga, O. Tago, M. Udagawa, Y. Kamiyama et al., Isolated cutaneous manifestation of IgG4-related disease, J Clin Pathol, vol.65, issue.9, pp.815-823, 2012.

S. Dhar, L. Liani, K. Patole, and S. Dhar, Cutaneous plasmacytosis: A rare entity with unique presentation, Indian J Dermatol Venereol Leprol, vol.83, issue.6, pp.673-679, 2017.

P. Lu, L. Shih, Y. Kuo, and T. , Cutaneous plasmacytosis: a clinicopathologic study of 12 cases in Taiwan revealing heterogeneous underlying causes, Int J Dermatol, vol.54, issue.10, pp.1132-1139, 2015.

R. Honda, L. Cerroni, A. Tanikawa, T. Ebihara, M. Amagai et al., Cutaneous plasmacytosis: report of 6 cases with or without systemic involvement, J Am Acad Dermatol, vol.68, issue.6, pp.978-85, 2013.

X. D. Han, S. Lee, S. H. Tan, W. Chong, S. K. Ng et al., Cutaneous Plasmacytosis: A Clinicopathologic Study of a Series of Cases and Their Treatment Outcomes, Am J Dermatopathol, vol.40, issue.1, pp.36-42, 2018.

J. Ahn, Y. , Y. Shin, M. Lee, S. Kim et al., Case of isolated benign primary cutaneous plasmacytosis in a child, J Dermatol, vol.38, issue.4, pp.364-371, 2011.

D. A. Porto, S. Sutton, J. B. Wilson, R. K. Scupham, M. S. Stone et al., Lymphoplasmacytic plaque in children: a report of two new cases with review of the literature, Journal of cutaneous pathology, vol.40, issue.1, pp.50-55, 2013.

I. Moulonguet, S. Hadj-rabia, N. Gounod, C. Bodemer, and S. Fraitag, Tibial lymphoplasmacytic plaque: a new, illustrative case of a recently and poorly recognized benign lesion in children, Dermatology (Basel), vol.225, issue.1, pp.27-30, 2012.

I. Fried, T. Wiesner, and L. Cerroni, Pretibial lymphoplasmacytic plaque in children, Arch Dermatol, vol.146, issue.1, pp.95-101, 2010.

C. B. Meireles, L. C. Maia, G. C. Soares, I. Teodoro, . Gadelha-m-do et al., Atypical presentations of cutaneous leishmaniasis: A systematic review, Acta Trop. août, vol.172, pp.240-54, 2017.

. Serment-d'hippocrate,

, Au moment d'être admis(e) à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité

, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux

, Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies

, Même sous la contrainte, je ne ferai pas usage de mes connaissances contre les lois de l'humanité

, Je ne tromperai jamais leur confiance et n'exploiterai pas le pouvoir hérité des circonstances pour forcer les consciences

, Reçu(e) à l'intérieur des maisons, je respecterai les secrets des foyers et ma conduite ne servira pas à corrompre les moeurs

, Je ferai tout pour soulager les souffrances. Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément

, Je n'entreprendrai rien qui dépasse mes compétences. Je les entretiendrai et les perfectionnerai pour assurer au mieux les services qui me seront demandés

, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité

, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses

, que je sois déshonoré(e) et méprisé(e) si j'y manque